Physician profile
Scott R Steele
NPI 1407827793
$28,388.58
in general payments reported to CMS, 2019-2025
13 companies · $843 in 2025
The $843 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $101 · 2021: $18.47 · 2022: $527 · 2023: $290 · 2024: $6,400 · 2025: $843.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,724 · Food and Beverage: $1,809 · Travel and Lodging: $1,001.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,723.63 |
| Food and Beverage | $1,808.68 |
| Travel and Lodging | $1,001.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $19,554.34 | 2019-2022 | |
| Medical Device Business Services, INC. | $5,942.75 | 2024 | Enseal |
| Medtronic, INC. | $731.09 | 2022-2025 | Signia, Ligasure, Eea |
| Ethicon US, LLC | $554.70 | 2021-2025 | Enseal, Contour, Echelon Flex |
| Prescient Surgical | $445.55 | 2019 | |
| Conmed Corporation | $301.90 | 2019-2022 | |
| Intuitive Surgical, INC. | $251.22 | 2019-2024 | |
| Dilon Technologies, INC. | $158.91 | 2025 | Hemoblast Bellows |
| Innovation Technologies INC | $156.82 | 2025 | Irrisept |
| Pacira Pharmaceuticals Incorporated | $121.34 | 2019 | |
| Covidien Lp | $78.22 | 2019 | |
| Baxter Healthcare | $65.86 | 2022-2024 | Tisseel |
| Guard Medical INC. | $25.88 | 2025 | Npseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Steele listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.